SkyePharma PLC Company Profile (NASDAQ:SKYEY)

About SkyePharma PLC (NASDAQ:SKYEY)

SkyePharma PLC logoSkyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: $7.00
  • 200 Day Moving Avg: $6.00
  • 52 Week Range: $3.95 - $6.97
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
Profitability:
  • Net Margins: 32.70%
  • Return on Equity: 79.41%
  • Return on Assets: 35.64%
Misc:
  • Average Volume: 100 shs.
 

Frequently Asked Questions for SkyePharma PLC (NASDAQ:SKYEY)

What is SkyePharma PLC's stock symbol?

SkyePharma PLC trades on the NASDAQ under the ticker symbol "SKYEY."

Who are some of SkyePharma PLC's key competitors?

How do I buy SkyePharma PLC stock?

Shares of SkyePharma PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SkyePharma PLC's stock price today?

One share of SkyePharma PLC stock can currently be purchased for approximately $6.28.


MarketBeat Community Rating for SkyePharma PLC (NASDAQ SKYEY)
Community Ranking:  1.1 out of 5 ()
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about SkyePharma PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for SkyePharma PLC (NASDAQ:SKYEY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SkyePharma PLC (NASDAQ:SKYEY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for SkyePharma PLC (NASDAQ:SKYEY)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SkyePharma PLC (NASDAQ:SKYEY)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for SkyePharma PLC (NASDAQ:SKYEY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for SkyePharma PLC (NASDAQ:SKYEY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for SkyePharma PLC (NASDAQ:SKYEY)
Latest Headlines for SkyePharma PLC (NASDAQ:SKYEY)
Source:

Social

Chart

SkyePharma PLC (SKYEY) Chart for Saturday, June, 24, 2017

This page was last updated on 6/24/2017 by MarketBeat.com Staff